Correction: Feasibility of Using Ceftazidime-Avibactam as a Therapeutic Option for Bloodstream Infections Caused by Multidrug-Resistant Enterobacterales and Pseudomonas aeruginosa Based on Its Susceptibility Profile
Ketan Priyadarshi, Sarumathi Dhandapani, Monika Sivaradjy, Lakshmi Shanmugam, Apurba S Sastry
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntibiotic Resistance in Bacteria · Antibiotic Use and Resistance · Antibiotics Pharmacokinetics and Efficacy
The Ethics Statement and Conflict of Interest Disclosures section of this article has been corrected to indicate that this study did involve human subjects or tissue.